Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
The Journal of Cardiovascular Surgery|July 28, 2011
Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experienceG Melloni, A Bandiera, V Gregorc, et al.British Journal of Haematology|January 1, 1994
Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluationP L Tazzari, A Bolognesi, D De Totero, et al.European Journal of Biochemistry|October 1, 1988
Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxinsP Casellas, D Dussossoy, A I Falasca, et al.Blood|April 15, 1995
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphomaL Pasqualucci, M Wasik, B A Teicher, et al.European Journal of Biochemistry|March 15, 1995
Ribosome-inactivating proteins (RNA N-glycosidases) from the seeds of Saponaria ocymoides and Vaccaria pyramidataA Bolognesi, F Olivieri, M G Battelli, et al.Tumori|September 1, 1996
Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: the impact of pathologic response on long-term resultsV Scattoni, A Bolognesi, C Cozzarini, et al.La Radiologia Medica|September 1, 1991
[Analysis of the results of 264 cases of small breast carcinoma treated with conservative surgery and radiotherapy]F Volterrani, D Aldrighetti, A Bolognesi, et al.Journal of Biological Regulators and Homeostatic Agents|April 6, 2012
Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6A Bolognesi, L Polito, V Scicchitano, et al.British Journal of Haematology|September 6, 2000
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteinsA Bolognesi, L Polito, P L Tazzari, et al.Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesotheliomaG L Ceresoli, L D Locati, A J Ferreri, et al.Pageof 9